companydata.dkcompanydata.dk

INNZ MEDICAL ApS: Financial statements 2023

CVR: 34490805

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

INNZ MEDICAL ApS (CVR 34490805) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 3,132,033 and a net result of DKK -92,950 compared with DKK 572,273 the year before. That is a decrease of 14.2% compared with the year before. Equity in the 2023 report amounted to DKK 244,114. The solvency ratio was 4.2%. The company had 4 employees in the financial year.

Gross Profit
DKK 3,132,033
Profit/Loss
DKK -92,950
Equity
DKK 244,114
Total Assets
DKK 5,768,247
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-3.1M-93K244K4
2022-3.6M572K837K4
2021-3.4M616K865K4
2020-2.5M-23K249K4
2019-2.2M78K271K4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

INNZ MEDICAL ApS: The 2022 annual report is outMar 16, 2023

INNZ MEDICAL ApS has published its annual report for 2022. Gross profit came to DKK 3,649,545, and the net result was DKK 572,273.

About INNZ MEDICAL ApS

INNZ MEDICAL ApS is a Danish company of the type Anpartsselskab based in Hobro, founded in 2012. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Dheeraj Bansal and Steen Hansen. The company is owned by Bansal Group AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 2,573,854 and a net result of DKK -708,583 compared with DKK -273,008 the year before. Equity in the 2025 report amounted to DKK -737,476.

Source: annual report 2025, Danish Business Authority